Advertisement
UK markets open in 6 hours 53 minutes

  • NIKKEI 225

    38,079.70
    0.00 (0.00%)
     

  • HANG SENG

    16,385.87
    +134.03 (+0.82%)
     

  • CRUDE OIL

    82.60
    -0.13 (-0.16%)
     

  • GOLD FUTURES

    2,395.10
    -2.90 (-0.12%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • Bitcoin GBP

    50,909.39
    +1,484.95 (+3.00%)
     

  • CMC Crypto 200

    1,311.71
    +426.17 (+48.16%)
     

  • NASDAQ Composite

    15,601.50
    -81.87 (-0.52%)
     

  • UK FTSE All Share

    4,290.02
    +17.00 (+0.40%)
     
Money:

Best mortgage deals of the week

As possibility of multiple interest rate cuts dwindle here's what banks and building societies are offering

MannKind (MNKD) in Focus: Stock Moves 7.8% Higher

Zacks Equity Research
Updated

MannKind Corporation MNKD was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $1.85 to $2.29 in the past one-month time frame.

The stock gained after the company reported that the FDA has approved an update to Afrezza's prescribing information.

The company has seen one negative estimate revisions in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few months, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

MannKind currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.  

MannKind Corporation Price

MannKind Corporation Price | MannKind Corporation Quote

ADVERTISEMENT

A better-ranked stock in the Medical - Biomedical and Genetics industry is Ligand Pharmaceuticals Incorporated LGND, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is MNKD going up? Or down? Predict to see what others think: Up or Down

Will You Make a Fortune on the Shift to Electric Cars?

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
MannKind Corporation (MNKD) : Free Stock Analysis Report
 
Ligand Pharmaceuticals Incorporated (LGND) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research